SCHEMBL5278263

SCHEMBL5278263

C=CCn1c(C)cs/c1=N\N=C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
KDM4E B2RXH2 5/20 0.38
POLB P06746 2/20 0.36
LMNA P02545 4/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 9/20 0.34
KMT2A Q03164 9/20 0.34
ALDH1A1 P00352 8/20 0.34
GAA P10253 3/20 0.34
L3MBTL1 Q9Y468 4/20 0.34
MAPK1 P28482 3/20 0.34
HTT P42858 2/20 0.34
THRB P10828 1/20 0.34
HSD17B10 Q99714 1/20 0.33
HPGD P15428 2/20 0.32
HCRTR1 O43613 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5278267 1.00 MAPT (0.56) MAPTNPC1RAB9AKDM4EPOLB
SCHEMBL5280017 0.81 MAPT (0.39) MAPTNPC1RAB9ALMNATSHR
SCHEMBL6271996 0.81 POLB (0.49) MAPTNPC1RAB9AKDM4EPOLB
SCHEMBL5285275 0.78 ALDH1A1 (0.49) MAPTNPC1RAB9AKDM4EPOLB
SCHEMBL5285272 0.78 ALDH1A1 (0.49) MAPTNPC1RAB9AKDM4EPOLB
SCHEMBL5279221 0.78 LMNA (0.40) MAPTNPC1RAB9AKDM4EPOLB
SCHEMBL5281464 0.78 SMN1; SMN2 (0.44) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL5281467 0.78 SMN1; SMN2 (0.44) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL4615714 0.78 MAPT (0.55) MAPTNPC1RAB9AKDM4EPOLB
SCHEMBL4615717 0.78 MAPT (0.55) MAPTNPC1RAB9AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885NPC1 4843/4885RAB9A 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.